These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25461287)

  • 1. S-nitrosocaptopril nanoparticles as nitric oxide-liberating and transnitrosylating anti-infective technology.
    Mordorski B; Pelgrift R; Adler B; Krausz A; da Costa Neto AB; Liang H; Gunther L; Clendaniel A; Harper S; Friedman JM; Nosanchuk JD; Nacharaju P; Friedman AJ
    Nanomedicine; 2015 Feb; 11(2):283-91. PubMed ID: 25461287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione.
    Friedman AJ; Blecher K; Schairer D; Tuckman-Vernon C; Nacharaju P; Sanchez D; Gialanella P; Martinez LR; Friedman JM; Nosanchuk JD
    Nitric Oxide; 2011 Nov; 25(4):381-6. PubMed ID: 21946032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response.
    Nacharaju P; Tuckman-Vernon C; Maier KE; Chouake J; Friedman A; Cabrales P; Friedman JM
    Nitric Oxide; 2012 Oct; 27(3):150-60. PubMed ID: 22705913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.
    Mihu MR; Cabral V; Pattabhi R; Tar MT; Davies KP; Friedman AJ; Martinez LR; Nosanchuk JD
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds.
    Hlaing SP; Kim J; Lee J; Hasan N; Cao J; Naeem M; Lee EH; Shin JH; Jung Y; Lee BL; Jhun BH; Yoo JW
    Eur J Pharm Biopharm; 2018 Nov; 132():94-102. PubMed ID: 30223029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection.
    Martinez LR; Han G; Chacko M; Mihu MR; Jacobson M; Gialanella P; Friedman AJ; Nosanchuk JD; Friedman JM
    J Invest Dermatol; 2009 Oct; 129(10):2463-9. PubMed ID: 19387479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles and current applications of S-nitrosoglutathione in anti-infective biomaterials.
    Qian H; Ye Z; Pi L; Ao J
    Mater Today Bio; 2022 Dec; 16():100419. PubMed ID: 36105674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds.
    Chouake J; Schairer D; Kutner A; Sanchez DA; Makdisi J; Blecher-Paz K; Nacharaju P; Tuckman-Vernon C; Gialanella P; Friedman JM; Nosanchuk JD; Friedman AJ
    J Drugs Dermatol; 2012 Dec; 11(12):1471-7. PubMed ID: 23377518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection.
    Han G; Martinez LR; Mihu MR; Friedman AJ; Friedman JM; Nosanchuk JD
    PLoS One; 2009 Nov; 4(11):e7804. PubMed ID: 19915659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferriheme catalyzes nitric oxide reaction with glutathione to form S-nitrosoglutathione: A novel mechanism for formation of S-nitrosothiols.
    Nagababu E
    Free Radic Biol Med; 2016 Dec; 101():296-304. PubMed ID: 27693379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional Antimicrobial Polypeptide-Selenium Nanoparticles Combat Drug-Resistant Bacteria.
    Huang T; Holden JA; Reynolds EC; Heath DE; O'Brien-Simpson NM; O'Connor AJ
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55696-55709. PubMed ID: 33249831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.
    Wu W; Gaucher C; Diab R; Fries I; Xiao YL; Hu XM; Maincent P; Sapin-Minet A
    Eur J Pharm Biopharm; 2015 Jan; 89():1-8. PubMed ID: 25448077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric Oxide-Releasing
    Lee J; Kwak D; Kim H; Kim J; Hlaing SP; Hasan N; Cao J; Yoo JW
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32630779
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and characterization of biogenic selenium nanoparticles with antimicrobial properties made by Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Pseudomonas aeruginosa.
    Medina Cruz D; Mi G; Webster TJ
    J Biomed Mater Res A; 2018 May; 106(5):1400-1412. PubMed ID: 29356322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-Nitrosoglutathione-Based Nitric Oxide-Releasing Nanofibers Exhibit Dual Antimicrobial and Antithrombotic Activity for Biomedical Applications.
    Douglass M; Hopkins S; Pandey R; Singha P; Norman M; Handa H
    Macromol Biosci; 2021 Jan; 21(1):e2000248. PubMed ID: 33021079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide releasing two-part creams containing S-nitrosoglutathione and zinc oxide for potential topical antimicrobial applications.
    Doverspike JC; Zhou Y; Wu J; Tan X; Xi C; Meyerhoff ME
    Nitric Oxide; 2019 Sep; 90():1-9. PubMed ID: 31170453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis.
    Cardozo VF; Lancheros CA; Narciso AM; Valereto EC; Kobayashi RK; Seabra AB; Nakazato G
    Int J Pharm; 2014 Oct; 473(1-2):20-9. PubMed ID: 24979535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatible biodegradable polymeric antibacterial nanoparticles for enhancing the effects of a third-generation cephalosporin against resistant bacteria.
    Mushtaq S; Khan JA; Rabbani F; Latif U; Arfan M; Yameen MA
    J Med Microbiol; 2017 Mar; 66(3):318-327. PubMed ID: 28150580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses.
    Schairer D; Martinez LR; Blecher K; Chouake J; Nacharaju P; Gialanella P; Friedman JM; Nosanchuk JD; Friedman A
    Virulence; 2012; 3(1):62-7. PubMed ID: 22286699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.